This IPO is roaring in the Gray Market oversubscribed more than 9 times in just 2 days. This IPO is roaring in the gray market, more than 9 times subscription in just 2 days

If you are looking for an opportunity to earn bumper income through IPO in the share market, then there is a very good news for you. The IPO of Q-Line Biotech, a small but strong company working in the in-vitro diagnostics and healthcare solutions segment, has opened for investment on May 21. Within the first two days, this IPO has received a very strong response from investors. According to the figures, this IPO has been subscribed more than 9 times in two days. Not only this, its shares are also making huge waves in the gray market, due to which investors are expecting huge profits on the day of listing.

Share worth Rs 343, signs of profit at Rs 130 per share on listing

Q-Line Biotech has fixed the upper price band for its IPO at Rs 343. At the same time, the craze for its shares is continuously increasing in the gray market. According to market experts, the gray market premium (GMP) of the company has increased to Rs 130. According to the current GMP, this stock can be listed in the market at Rs 473 (343+130). This simply means that the lucky investors who will be allotted shares in this IPO can get a huge profit of about 38% on the day of listing.

Know what are the important dates (IPO Timeline)

If you want to bet in this IPO, you still have a chance left. The IPO of Q-Line Biotech will remain open for investment till 25 May 2026. After this, the allotment of shares of the company will be finalized on 26 May 2026. Those investors who will not be able to get their shares, their refund will be processed after this. At the same time, the company’s shares are going to make a big entry in the domestic stock market on Friday, May 29, 2026.

From common investors to institutional buyers, money is lost from all sides.

If we look at the subscription data of the first two days, this IPO total 9.87 times Has been subscribed. The response of different categories is as follows:

• Retail Investors (Common Investors): Maximum enthusiasm was seen in this category and it was subscribed 10.07 times.

• Non-Institutional Investors (NII): The heaviest stake has been placed in the quota of non-institutional investors at 15.62 times.

• Qualified Institutional Buyers (QIB): 5.19 times subscription has also been received in the category of qualified institutional buyers.

Key figures and investment limits of IPO

If you are a common (retail) investor, then as per the rules, you can place bets only for a maximum of 2 lots in this IPO. A total of 800 shares are included in 2 lots of this IPO. That is, according to the upper price band, you will get minimum and maximum price in this IPO. Investment of Rs 2,74,400 Will have to do.

What does the company do and who are the promoters?

Q-Line Biotech, started in the year 2010, mainly operates in the in-vitro diagnostics (IVD) and healthcare solutions segment. This company manufactures diagnostic reagents, rapid testing kits, molecular diagnostics products, pathology equipment and other related consumables. This company has the great support of veteran and renowned market investor Vikas Khemani. The promoters of the company include Saurabh Garg, Amita Garg, Ayush Garg, Ajay Kumar Mahanty and Abhay Agarwal. Before the IPO, the total stake of the promoters in the company is 96.77 percent. The company will use the proceeds from this IPO mainly to meet its working capital requirements, repay old loans and for general corporate purposes.